Endpoints of clinical trials for muscle-invasive bladder cancer

Prog Clin Biol Res. 1990:353:65-74.
No abstract available

Publication types

  • Guideline
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic / methods*
  • Humans
  • Muscles / pathology
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Pilot Projects
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Research Design*
  • Survival Rate
  • Urinary Bladder Neoplasms / mortality
  • Urinary Bladder Neoplasms / pathology
  • Urinary Bladder Neoplasms / therapy*

Substances

  • Antineoplastic Agents